CNTB
NASDAQ · Biotechnology
Connect Biopharma Holdings L
$2.36
+0.03 (+1.29%)
Open$2.33
Previous Close$2.33
Day High$2.40
Day Low$2.27
52W High$3.82
52W Low$0.70
Volume—
Avg Volume145.9K
Market Cap156.15M
P/E Ratio—
EPS$-0.81
SectorBiotechnology
Analyst Ratings
Strong Buy
11 analysts
Price Target
+771.2% upside
Current
$2.36
$2.36
Target
$20.56
$20.56
$15.18
$20.56 avg
$23.56
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 72.8K | 69.44M | 70.73M |
| Net Income | -65,953,677 | 4.31M | 5.04M |
| Profit Margin | -86,687.5% | 6.2% | 7.1% |
| EBITDA | -67,574,729 | 5.85M | 6.49M |
| Free Cash Flow | — | 3.99M | 3.58M |
| Rev Growth | — | +2.8% | -4.7% |
| Debt/Equity | — | 0.90 | 0.87 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $210.39 | -0.18% | 88.1 | 372.39B |
| AMGN | Amgen Inc | $326.31 | -2.95% | 23.0 | 179.23B |
| GILD | Gilead Sciences Inc | $129.58 | -1.88% | 17.4 | 160.50B |
| VRTX | Vertex Pharmaceuticals Inc | $436.95 | -2.99% | 26.4 | 114.32B |
| REGN | Regeneron Pharmaceuticals | $698.25 | -2.05% | 16.7 | 73.89B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.98 | -2.20% | 66.6 | 38.43B |